Geneva – Unitaid is seeking to fund smart, innovative projects that will help eliminate cervical cancer, a leading cause of death in low- and middle-income countries, particularly among women with HIV.
At 44 years of age, Jason was diagnosed with Stage IV HPV Throat Cancer. With a wife and three children, he was determined to survive. Now he wants to stop anyone else from having to go through what he did.
IPVS was delighted to support and endorse the 4th Latin American Human Papillomavirus Symposium on April 26-27 in Buenos Aires Argentina.
The critical role of stakeholder collaborations: Aiming for the elimination of HPV-related disease in Europe
Despite the availability of a vaccine proven to be an effective primary prevention measure to reduce the burden of HPV-related cancers, many challenges remain to achieve universal, gender-neutral HPV vaccination in the EU. Such challenges were discussed at a roundtable of EU and national experts and patients in Brussels in December 2017.
Interesting article by Elsevier, including a top 5 of the latest studies published in Papillomavirus Research Journal that are contributing to ending HPV transmission.
IPVS publishes a Policy Statement: Moving towards Elimination of Cervical Cancer as a Public Health Problem
IPVS is releasing a Call to Action to health authorities to adhere to international standards developed by WHO